Healio
Covers PMOS, fertility, pregnancy and menopause, and why treating obesity can help beyond the scale. A clinician explainer with little on GLP-1s.
Recap by typeshit. Full story at Healio.
Half of people with diabetes for 10 years or more said they were very satisfied on a GLP-1. Gen Z users were the most likely to stop and restart treatment.
64% of current users faced some negative reaction. Men, BIPOC respondents and the newly diagnosed reported it most, while 69% of boomers felt none.
The workflow uses glutathione or sulfatase triggers to target organelles and tumors in mice, and the authors say it takes 92 to 115 days to run.
A University of Pennsylvania mouse study found on-off GLP-1 use left mice 20 per cent heavier than those kept on the drug, and doctors warn human effects are unknown.
The physician-led longevity service lists GLP-1 management and peptide therapy among its offerings and opens first inside Everhaus Las Vegas in early 2027.
A Harvard and Copenhagen review found 43 percent of users eat too little protein, and a Northwestern study saw deficiencies in nearly one in six teens.
Loading…